Electronic Labeling Study By GAO Yields “No Consensus,” Avoids Cost Issue
This article was originally published in The Pink Sheet Daily
Executive Summary
In study mandated by FDASIA, GAO says there are advantages and disadvantages to switching to an electronic-only system for distributing drug label information, but offers no conclusions.